Labshake search

651 - 700 of 2921 citations for Recombinant Human F13B His tagged since 2019

• Depletion of alloreactive B cells by chimeric alloantigen receptor T cells with drug resistance to prevent antibody-mediated rejection in solid organ transplantation

  Anna C. Dragon, et al., bioRxiv - Immunology 2023

  Quote: ... the LEGENDplex human CD8/NK Panel (BioLegend) was performed according to the manufacturer’s instructions ...
• Caspase-2 is essential for proliferation and self-renewal of nucleophosmin-mutated acute myeloid leukemia

  Dharaniya Sakthivel, et al., bioRxiv - Cancer Biology 2023

  Quote: ... APC anti-human CD14 (clone 63D3; BioLegend). Alexa Fluor 647 Phalloidin was purchased from Cell Signaling Technology ...
• Solid tumor-on-chip model for efficacy and safety assessment of CAR-T cell therapy

  Tengku Ibrahim Maulana, et al., bioRxiv - Bioengineering 2023

  Quote: ... anti-human CD4 APC/Fire750 (357426; BioLegend), anti-human CD8a PerCP (300922 ...
• Soluble CTLA-4 mainly produced by Treg cells inhibits type 1 inflammation without hindering type 2 immunity to allow for inflammation resolution

  Motonao Osaki, Shimon Sakaguchi, bioRxiv - Immunology 2023

  Quote: ... The anti-human IgG Fc Antibody (BioLegend) and the Sheep Anti-Rat IgG Dynabeads (Thermo Fisher Scientific ...
• Macrophage Migration Inhibitory Factor on Apoptotic Extracellular Vesicles Regulates Compensatory Proliferation

  Safia A. Essien, et al., bioRxiv - Cell Biology 2023

  Quote: ... The Human Anti-CD74 antibody (BioLegend, 326802) was stored at 4°C ...
• Therapeutic Prime/Pull Vaccination of HSV-2 Infected Guinea Pigs with the Ribonucleotide Reductase 2 (RR2) Protein and CXCL11 Chemokine Boosts Antiviral Local Tissue-Resident and Effector Memory CD4⁺ and CD8⁺ T Cells and Protects Against Recurrent Genital Herpes

  Afshana Quadiri, et al., bioRxiv - Immunology 2023

  Quote: ... anti-mouse/human CD44 (clone IM7, Biolegend), anti-mouse CD69 (clone H1.2F3 ...
• Solid tumor-on-chip model for efficacy and safety assessment of CAR-T cell therapy

  Tengku Ibrahim Maulana, et al., bioRxiv - Bioengineering 2023

  Quote: ... anti-human CD3 PE/Cyanine7 (317334; BioLegend), anti-human CD4 APC/Fire750 (357426 ...
• Vascularised Cardiac Spheroids-on-a-Chip for Testing the Toxicity of Therapeutics

  Stefania Di Cio, et al., bioRxiv - Bioengineering 2023

  Quote: ... APC anti- human CD140b (PDGFRβ, Biolegend 323608); Alexa Fluor 488 anti-fibronectin (eBioscience™) ...
• Therapeutic immune cell engineering with an mRNA : AAV-Sleeping Beauty composite system

  Lupeng Ye, et al., bioRxiv - Bioengineering 2023

  Quote: ... and 200U/mL human IL-2 (BioLegend).
• Therapeutic immune cell engineering with an mRNA : AAV-Sleeping Beauty composite system

  Lupeng Ye, et al., bioRxiv - Bioengineering 2023

  Quote: ... 20ng/mL of human GM-CSF (BioLegend) was used to differentiate monocytes into macrophages for 7 days ...
• Single-cell atlas of bronchoalveolar lavage from preschool cystic fibrosis reveals new cell phenotypes

  Jovana Maksimovic, et al., bioRxiv - Systems Biology 2022

  Quote: ... Human TruStain FcX FC blocking reagent (BioLegend) was added according to manufacturers’ instructions for 10min on ice ...
• Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function

  Alice Santi, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and human TruStain FcXTM (1/200, BioLegend) in 100 μl of FACS buffer for 45min on ice ...
• Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function

  Alice Santi, et al., bioRxiv - Cancer Biology 2023

  Quote: ... and human TruStain FcXTM (1/200, BioLegend) in 100 μl of FACS buffer for 45min on ice ...
• T-cell derived extracellular vesicles prime macrophages for improved STING based cancer immunotherapy

  Aida S. Hansen, et al., bioRxiv - Immunology 2023

  Quote: ... or human IgG1 (clone MOPC-21) (Biolegend) for 30 min ...
• Engineered cytokine/antibody fusion proteins improve delivery of IL-2 to pro-inflammatory cells and promote antitumor activity

  Elissa K. Leonard, et al., bioRxiv - Bioengineering 2023

  Quote: ... BV605 anti-human CD8 (clone SK1, Biolegend); BV421 anti-human CD25 (clone M-A251 ...
• Co-engagement of TIGIT⁺ immune cells to PD-L1⁺ tumours by a bispecific antibody potentiates T-cell response and tumour control

  Xiaopei Cui, et al., bioRxiv - Immunology 2023

  Quote: ... APC/CY7 anti human CD16 (Biolegend/302017), FITC anti human CD107a antibodies (Biolegend/328606 ...
• Co-engagement of TIGIT⁺ immune cells to PD-L1⁺ tumours by a bispecific antibody potentiates T-cell response and tumour control

  Xiaopei Cui, et al., bioRxiv - Immunology 2023

  Quote: ... PE/CY7 anti-human TIGIT (Biolegend/372714). Binding of anti-TIGIT antibodies HB0036/HB0030 to cell surface was detected by APC-anti his (Biolegend/362605) ...
• Luminal epithelial cells integrate variable responses to aging into stereotypical changes that underlie breast cancer susceptibility

  Rosalyn W. Sayaman, et al., bioRxiv - Cancer Biology 2022

  Quote: ... or anti-human CD133-PE (BioLegend, clone7), and anti-human CD271-APC (BioLegend ...
• Therapeutic immune cell engineering with an mRNA : AAV-Sleeping Beauty composite system

  Lupeng Ye, et al., bioRxiv - Bioengineering 2023

  Quote: ... and 400U/mL human IL-2 (BioLegend). T cells were activated with Dynabeads Human T-Activator CD3/CD28 (ThermoFisher ...
• Carcinoma-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment

  Emma D. Wrenn, et al., bioRxiv - Cancer Biology 2023

  Quote: ... 2.5 μL human TruStain FcX (BioLegend #42230) was added per sample and incubated at 4°C for 10 minutes ...
• Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity of human CAR-iMACs in solid tumors

  Xudong Wang, et al., bioRxiv - Immunology 2023

  Quote: ... FITC Human IgG1 Isotype Control (403507, Biolegend), APC anti-human CD206 (321109 ...
• Gut microbiota and maternal immune transfer at birth influence pre-allergic clinical outcome

  Remy Villette, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human IgE PerCP-Cy5.5 (Biolegend, BLE325512) and human Fc biotin (009-060-008) ...
• Metabolic Reprogramming via targeting ACOD1 promotes polarization and anti-tumor activity of human CAR-iMACs in solid tumors

  Xudong Wang, et al., bioRxiv - Immunology 2023

  Quote: ... APC Human IgG1 Isotype Control (403505, Biolegend), FITC Human IgG1 Isotype Control (403507 ...
• Validation of ligand tetramers for the detection of antigen-specific lymphocytes

  Kristin S. Fitzpatrick, et al., bioRxiv - Immunology 2022

  Quote: ... anti-human HLA-ABC (W6/32, BioLegend), and anti-mouse H-2Kb (Y3 ...
• B-Cell Precursor Acute Lymphoblastic Leukemia elicits an Interferon-α/β response in Bone Marrow-derived Mesenchymal Stroma

  Mandy W. E. Smeets, et al., bioRxiv - Cancer Biology 2023

  Quote: ... PE anti-human CD4 and CD56 (Biolegend), Brilliant violet (BV)421 anti-human CD8 (Biolegend) ...
• The CARD8 inflammasome drives CD4⁺ T-cell depletion in HIV-1 infection

  Qiankun Wang, Liang Shan, bioRxiv - Microbiology 2023

  Quote: ... anti-human CD45-Pacific Blue (BioLegend # 304029), anti-human CD3-BV650 (BioLegend # 317324) ...
• Co-engagement of TIGIT⁺ immune cells to PD-L1⁺ tumours by a bispecific antibody potentiates T-cell response and tumour control

  Xiaopei Cui, et al., bioRxiv - Immunology 2023

  Quote: ... FITC anti human CD107a antibodies (Biolegend/328606) on ice for 30 min and then subjected to FACS analysis (BD/Canto II ...
• Designer small molecule control system based on Minocycline induced disruption of protein-protein interaction

  Ram Jha, et al., bioRxiv - Molecular Biology 2023

  Quote: ... APC anti-human EGFR antibody (Biolegend, 352905), Alexa Fluor® 488 anti-human EGFR antibody (Biolegend ...
• Solid tumor-on-chip model for efficacy and safety assessment of CAR-T cell therapy

  Tengku Ibrahim Maulana, et al., bioRxiv - Bioengineering 2023

  Quote: ... and anti-human CD25 BV421 (302630; BioLegend). Detailed information on the antibodies is summarized in Supplementary Table 2 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD3-BV605 (clone UCHT1, BioLegend), anti-human CD14-BV510 (clone M5E2 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD21-APC (clone Bu32, BioLegend), anti-human CD24-BV605 (clone ML5 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD14-BV510 (clone M5E2, BioLegend), anti-human CD14-BV605 (clone M5E2 ...
• Analysis of regulatory network modules in hundreds of human stem cell lines reveals complex epigenetic and genetic factors contribute to pluripotency state differences between subpopulations

  Timothy D. Arthur, et al., bioRxiv - Genomics 2023

  Quote: ... and SSEA-4 (PE anti-human, Biolegend). Pluripotency was also examined using PluriTest-RNAseq 70 ...
• Bacterial pore-forming toxin pneumolysin drives pathogenicity through shed toxin-loaded host extracellular vesicles

  Saba Parveen, et al., bioRxiv - Microbiology 2023

  Quote: ... PE-anti-human CD83 clone HB15 (Biolegend) as per manufacturer’s instructions ...
• Facile generation of biepitopic antibodies with intrinsic agonism for activating receptors in the tumor necrosis factor superfamily

  Harkamal S. Jhajj, et al., bioRxiv - Bioengineering 2023

  Quote: ... and APC anti-human CD25 (BioLegend, 302610) antibodies at 1:200 dilution each on ice for 5 min ...
• Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes

  Brenda Kapingidza, et al., bioRxiv - Immunology 2023

  Quote: ... BV570 anti-human CD16 (clone 3G8, Biolegend), BV605 anti-human CD14 (clone M5E2 ...
• Fine needle aspiration of human lymph nodes reveals cell populations and soluble interactors pivotal to immunological priming

  Nicholas M. Provine, et al., bioRxiv - Immunology 2023

  Quote: ... TotalSeq-C Human Universal Cocktail V1.0 (BioLegend) was prepared per manufacturer’s instructions and added to the cells without washing ...
• eQTL mapping in fetal-like pancreatic progenitor cells reveals early developmental insights into diabetes risk

  Jennifer P. Nguyen, et al., bioRxiv - Genomics 2023

  Quote: ... and SSEA-4 (PE anti-human, Biolegend) 35 ...
• Engineered Immunogens to Elicit Antibodies Against Conserved Coronavirus Epitopes

  Brenda Kapingidza, et al., bioRxiv - Immunology 2023

  Quote: ... BV605 anti-human CD14 (clone M5E2, Biolegend), and BV711 anti-human IgM (clone G20-127 ...
• Unraveling the Phenotypic States of Human innate-like T Cells: Comparative Insights with Conventional T Cells and Mouse Models

  Liyen Loh, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD45 (clone HI30, Biolegend #304002) and anti-human CD235a (clone HI264 ...
• Perivascular cells function as mechano-structural sensors of vascular capillaries

  Cristiane M. Franca, et al., bioRxiv - Bioengineering 2024

  Quote: ... APC/Cyanine7 anti-human CD90 (5E10, BioLegend), PE-Cy™5 Mouse Anti-Human CD235a (HIR2 ...
• Combining Cell-Intrinsic and -Extrinsic Resistance to HIV-1 By Engineering Hematopoietic Stem Cells for CCR5 Knockout and B Cell Secretion of Therapeutic Antibodies

  William N. Feist, et al., bioRxiv - Bioengineering 2024

  Quote: ... anti-human HLA-ABC (Biolegend, cat. 311426), anti-human CD33 (BD ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD24-BV605 (clone ML5, BioLegend), anti-human CD27-BV421 (clone O323 ...
• Generation of circulating autoreactive pre-plasma cells fueled by naïve B cells in celiac disease

  Ida Lindeman, et al., bioRxiv - Immunology 2023

  Quote: ... anti-human CD20-BV605 (clone 2H7, BioLegend), anti-human CD21-BV421 (clone 1048 ...
• Oncolytic adenovirus serotype 35 mediated tumor growth suppression via efficient activation and tumor infiltration of natural killer cells

  Ryosuke Ono, et al., bioRxiv - Cancer Biology 2023

  Quote: ... FITC-labeled anti-human CD3 antibody (BioLegend), APC/cyanine7-labeled anti-human CD69 antibody (BioLegend) ...
• Multi-omic QTL mapping in early developmental tissues reveals phenotypic and temporal complexity of regulatory variants underlying GWAS loci

  Timothy D. Arthur, et al., bioRxiv - Genomics 2024

  Quote: ... and SSEA-4 (PE anti-human, Biolegend). Pluripotency was also examined using PluriTest-RNAseq47.
• Islet-antigen reactive B cells display a unique phenotype and BCR repertoire in autoantibody positive and recent-onset type 1 diabetes patients

  Catherine A. Nicholas, et al., bioRxiv - Immunology 2024

  Quote: ... and anti-human CXCR5 (BioLegend, Cat#356939). Cells were stained for 15 minutes on ice in the dark ...
• Immunocompetent murine model of Ewing sarcoma reveals role for TGFβ inhibition to enhance immune infiltrates in Ewing tumors during radiation

  Jessica D. Daley, et al., bioRxiv - Cancer Biology 2024

  Quote: ... Human CD11b PerCP/Cyanine5.5 (Biolegend Inc 301328), CD56 ...
• Immunocompetent murine model of Ewing sarcoma reveals role for TGFβ inhibition to enhance immune infiltrates in Ewing tumors during radiation

  Jessica D. Daley, et al., bioRxiv - Cancer Biology 2024

  Quote: ... Human Ki-67 BV421 (Biolegend Inc 350506), and Human FoxP3 EF450 (Invitrogen 48477642) ...
• A 3D in vitro assay to study combined immune cell infiltration and cytotoxicity

  Ashleigh J Crawford, et al., bioRxiv - Cancer Biology 2024

  Quote: ... PE/Cyanine7 anti-human CD206 (Biolegend 321123). Unstained control samples were prepared via staining with APC Rat igG2a ...